MBL77 NO FURTHER A MYSTERY

mutations specified The reality that, as defined underneath, CLL therapy is based to the presence or absence of these mutations. The current consensus is usually that, besides clonal mutations, subclonal mutations which has a variant allelic frequency starting from five to 10% (and therefore under the edge of detection by standard molecular tactics